참고문헌 (61)

1. Agdeppa ED , Kepe V , Petri A , et al . 2003 . In vitro detection of (S)‐naproxen and ibuprofen binding to plaques in the Alzheimer's brain using the positron emission tomography molecular imaging probe 2‐(1‐[6‐[(2‐[(18)F]fluoroethyl)(methyl)amino]‐2‐naphthyl]ethylidene)malononitrile . Neuroscience 117 : 723 – 730 . 

2. Aizenstein HJ , Nebes RD , Saxton JA , et al . 2008 . Frequent amyloid deposition without significant cognitive impairment among the elderly . Arch Neurol 65 : 1509 – 1517 . 

   상세보기

3. Archer HA , Edison P , Brooks DJ , et al . 2006 . Amyloid load and cerebral atrophy in Alzheimer's disease: an 11C‐PIB positron emission tomography study . Ann Neurol 60 : 145 – 147 . 

   상세보기

4. Ballard C , Ziabreva I , Perry R , et al . 2006 . Differences in neuropathologic characteristics across the Lewy body dementia spectrum . Neurology 67 : 1931 – 1934 . 

   상세보기

5. Bennett DA , Schneider JA , Arvanitakis Z , et al . 2006 . Neuropathology of older persons without cognitive impairment from two community‐based studies . Neurology 66 : 1837 – 1844 . 

   상세보기

6. Bornebroek M , Verzijlbergen JF , Haan J , et al . 1996 . Potential for imaging cerebral amyloid deposits using 123I‐labelled serum amyloid P component and SPET . Nucl Med Commun 17 : 929 – 933 . 

   상세보기

7. Braak H , Braak E . 1991 . Neuropathological stageing of Alzheimer‐related changes . Acta Neuropathol 82 : 239 – 259 . 

   상세보기

8. Brooks DJ . 2009 . Imaging amyloid in Parkinson's disease dementia and dementia with Lewy bodies with positron emission tomography . Mov Disord 24 (Suppl 2) : S742 – S747 . 

9. Burack MA , Hartlein J , Flores HP , et al . 2010 . In vivo amyloid imaging in autopsy‐confirmed Parkinson disease with dementia . Neurology 74 : 77 – 84 . 

   상세보기

10. Edison P , Archer HA , Hinz R , et al . 2007 . Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study . Neurology 68 : 501 – 508 . 

    상세보기

11. Edison P , Rowe CC , Rinne JO , et al . 2008 . Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography . J Neurol Neurosurg Psychiatr 79 : 1331 – 1338 . 

12. Engler H , Forsberg A , Almkvist O , et al . 2006 . Two‐year follow‐up of amyloid deposition in patients with Alzheimer's disease . Brain 129 : 2856 – 2866 . 

    상세보기

13. Engler H , Santillo AF , Wang SX , et al . 2008 . In vivo amyloid imaging with PET in frontotemporal dementia . Eur J Nucl Med Mol Imaging 35 : 100 – 106 . 

    상세보기

14. Forsberg A , Engler H , Almkvist O , et al . 2008 . PET imaging of amyloid deposition in patients with mild cognitive impairment . Neurobiol Aging 29 : 1456 – 1465 . 

    상세보기

15. Friedland RP , Majocha RE , Reno JM , Lyle LR , Marotta CA . 1994 . Development of an anti‐A beta monoclonal antibody for in vivo imaging of amyloid angiopathy in Alzheimer's disease . Mol Neurobiol 9 : 107 – 113 . 

16. Galton CJ , Patterson K , Graham K , et al . 2001 . Differing patterns of temporal atrophy in Alzheimer's disease and semantic dementia . Neurology 57 : 216 – 225 . 

    상세보기

17. Gomperts SN , Rentz DM , Moran E , et al . 2008 . Imaging amyloid deposition in Lewy body diseases . Neurology 71 : 903 – 910 . 

    상세보기

18. Hansson O , Zetterberg H , Buchhave P , et al . 2006 . Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow‐up study . Lancet Neurol 5 : 228 – 234 . 

    상세보기

19. Hardy J , Selkoe DJ . 2002 . The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics . Science 297 : 353 – 356 . 

    상세보기

20. Hardy JA , Higgins GA . 1992 . Alzheimer's disease: the amyloid cascade hypothesis . Science 256 : 184 – 185 . 

    상세보기

21. Ikonomovic MD , Klunk WE , Abrahamson EE , et al . 2008 . Post‐mortem correlates of in vivo PiB‐PET amyloid imaging in a typical case of Alzheimer's disease . Brain 131 : 1630 – 1645 . 

    상세보기

22. Jack CR Jr , Lowe VJ , Senjem ML , et al . 2008 . 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment . Brain 131 : 665 – 680 . 

    상세보기

23. Jack CR Jr , Lowe VJ , Weigand SD , et al . 2009 . Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease . Brain 132 : 1355 – 1365 . 

    상세보기

24. Joachim CL , Morris JH , Selkoe DJ . 1989 . Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease . Am J Pathol 135 : 309 – 319 . 

    상세보기

25. Johnson KA , Gregas M , Becker JA , et al . 2007 . Imaging of amyloid burden and distribution in cerebral amyloid angiopathy . Ann Neurol 62 : 229 – 234 . 

    상세보기

26. Kemppainen NM , Aalto S , Wilson IA , et al . 2007 . PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment . Neurology 68 : 1603 – 1606 . 

    상세보기

27. Klunk WE , Engler H , Nordberg A , et al . 2004 . Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B . Annal Neurol 55 : 306 – 319 . 

28. Klunk WE , Mathis CA . 2008 . The future of amyloid‐beta imaging: a tale of radionuclides and tracer proliferation . Curr Opin Neurol 21 : 683 – 687 . 

    상세보기

29. Klunk WE , Price JC , Mathis CA , et al . 2007 . Amyloid deposition begins in the striatum of presenilin‐1 mutation carriers from two unrelated pedigrees . J Neurosci 27 : 6174 – 6184 . 

    상세보기

30. Koivunen J , Pirttila T , Kemppainen N , et al . 2008 . PET amyloid ligand [11C]PIB uptake and cerebrospinal fluid beta‐amyloid in mild cognitive impairment . Dementia Geriatr Cognit Disord 26 : 378 – 383 . 

31. Lockhart A , Lamb JR , Osredkar T , et al . 2007 . PIB is a non‐specific imaging marker of amyloid‐beta (Abeta) peptide‐related cerebral amyloidosis . Brain 130 : 2607 – 2615 . 

    상세보기

32. Lopresti BJ , Klunk WE , Mathis CA , et al . 2005 . Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis . J Nucl Med 46 : 1959 – 1972 . 

    상세보기

33. Lucignani G . 2009 . Clinical applications of PET amyloid imaging: an update . Eur J Nucl Med Mol Imaging 36 : 1185 – 1190 . 

    상세보기

34. Maggio JE , Stimson ER , Ghilardi JR , et al . 1992 . Reversible in vitro growth of Alzheimer disease beta‐amyloid plaques by deposition of labeled amyloid peptide . Proc Natl Acad Sci USA 89 : 5462 – 5466 . 

    상세보기

35. Mathis CA , Wang Y , Holt DP , et al . 2003 . Synthesis and evaluation of 11C‐labeled 6‐substituted 2‐arylbenzothiazoles as amyloid imaging agents . J Med Chem 46 : 2740 – 2754 . 

    상세보기

36. Mintun MA , Larossa GN , Sheline YI , et al . 2006 . [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease . Neurology 67 : 446 – 452 . 

37. Mormino , EC , Kluth , JT , Madison , CM , et al . 2009 . Episodic memory loss is related to hippocampal‐mediated beta‐amyloid deposition in elderly subjects . Brain 132 : 1310 – 1323 . 

    상세보기

38. Morris JC , Storandt M , Miller JP , et al . 2001 . Mild cognitive impairment represents early‐stage Alzheimer disease . Arch Neurol 58 : 397 – 405 . 

    상세보기

39. Nordberg A . 2004 . PET imaging of amyloid in Alzheimer's disease . Lancet Neurol 3 : 519 – 527 . 

    상세보기

40. Nordberg A . 2008 . Amyloid imaging in Alzheimer's disease . Neuropsychologia 46 : 1636 – 1641 . 

    상세보기

41. Pike KE , Savage G , Villemagne VL , et al . 2007 . Beta‐amyloid imaging and memory in non‐demented individuals: evidence for preclinical Alzheimer's disease . Brain 130 : 2837 – 2844 . 

42. Poduslo JF , Wengenack TM , Curran GL , et al . 2002 . Molecular targeting of Alzheimer's amyloid plaques for contrast‐enhanced magnetic resonance imaging . Neurobiol Disease 11 : 315 – 329 . 

43. Price JC , Klunk WE , Lopresti BJ , et al . 2005 . Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound‐B . J Cerebr Blood Flow Metabol 25 : 1528 – 1547 . 

44. Rabinovici GD , Furst AJ , O'Neil JP , et al . 2007 . 11C‐PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration . Neurology 68 : 1205 – 1212 . 

    상세보기

45. Rabinovici GD , Jagust WJ . 2009 . Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo . Behav Neurol 21 : 117 – 128 . 

46. Reiman EM , Chen K , Liu X , et al . 2009 . Fibrillar amyloid‐beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease . Proc Natl Acad Sci USA 106 : 6820 – 6825 . 

    상세보기

47. Rowe CC , Ackerman U , Browne W , et al . 2008 . Imaging of amyloid beta in Alzheimer's disease with 18F‐BAY94‐9172, a novel PET tracer: proof of mechanism . Lancet Neurol 7 : 129 – 135 . 

48. Rowe CC , Ng S , Ackermann U , et al . 2007 . Imaging beta‐amyloid burden in aging and dementia . Neurology 68 : 1718 – 1725 . 

49. Santens P , Petit H . 1997 . Positron emission tomography in dementia . Acta Neurol Belg 97 : 192 – 195 . 

    상세보기

50. Shoghi‐Jadid K , Small GW , Agdeppa ED , et al . 2002 . Localization of neurofibrillary tangles and beta‐amyloid plaques in the brains of living patients with Alzheimer disease . Am J Geriatr Psychiatr 10 : 24 – 35 . 

51. Small GW , Kepe V , Ercoli LM , et al . 2006 . PET of brain amyloid and tau in mild cognitive impairment . New Engl J Med 355 : 2652 – 2663 . 

52. Stozicka Z , Zilka N , Novak M . 2007 . Risk and protective factors for sporadic Alzheimer's disease . Acta Virologica 51 : 205 – 222 . 

    상세보기

53. Terry RD , Masliah E , Salmon DP , et al . 1991 . Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment . Annal Neurol 30 : 572 – 580 . 

54. Thal DR , Rub U , Orantes M , Braak H . 2002 . Phases of A beta‐deposition in the human brain and its relevance for the development of AD . Neurology 58 : 1791 – 1800 . 

    상세보기

55. Vandenberghe R , Thurfjell L , Owenius R , et al . 2008 . P1‐303: Phase I study of the 18F‐labelled benzothiazole derivative [18F]AH110690 as a biomarker of Alzheimer's disease‐related brain amyloidosis . Alzheimer's Dementia 4 : T308 – T308 . 

    상세보기

56. Verhoeff NPLG , Wilson AA , Takeshita S , et al . 2004 . In‐vivo imaging of Alzheimer disease beta‐amyloid with [11C]SB‐13 PET . Am J Geriatr Psychiatr 12 : 584 – 595 . 

57. Villemagne VL , Pike KE , Darby D , et al . 2008 . Abeta deposits in older non‐demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease . Neuropsychologia 46 : 1688 – 1697 . 

58. Wimo A , Winblad B , Aguero‐Torres H , von Strauss E . 2003 . The magnitude of dementia occurrence in the world . Alzheimer Disease Assoc Disord 17 : 63 – 67 . 

59. Wolk DA , Klunk W . 2009 . Update on amyloid imaging: from healthy aging to Alzheimer's disease . Curr Neurol Neurosci Rep 9 : 345 – 352 . 

60. Wolk DA , Price JC , Saxton JA , et al . 2009 . Amyloid imaging in mild cognitive impairment subtypes . Ann Neurol 65 : 557 – 568 . 

    상세보기

61. Zhuang Z‐P , Kung M‐P , Wilson A , et al . 2003 . Structure‐activity relationship of imidazo[1,2‐a]pyridines as ligands for detecting beta‐amyloid plaques in the brain . J Med Chem 46 : 237 – 243 .